Corient Private Wealth’s Abivax ABVX Stock Holding History
Bought
Maintained
Sold
Other funds holding ABVX
DGM
Corient Private Wealth's ABVX Position: Q3 2026 in Review
Corient Private Wealth opened a new position in Abivax (ABVX) in Q3 2026: 6,275 shares worth $621K. The stake represents ﹤0.01% of the portfolio and ranks #2324 among its holdings.
319 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.
- Corient Private Wealth held 6,275 shares of Abivax worth $621K as of Q3 2026.
- Abivax was a new Corient Private Wealth position in Q3 2026.
- Abivax made up ﹤0.01% of Corient Private Wealth's portfolio in Q3 2026, its #2324 holding.
- 319 funds tracked by Wall St. Rank held Abivax as of Q3 2026.
Based on Corient Private Wealth's 13F filing for Q3 2026, filed 16 Nov 2026.